← Eichor
Study identifier: NCT05629611 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy and Safety Evaluation of Vi-sealer

Condition: Benign Gynecologic Neoplasm  ·  Sponsor: Hyun Park

PhaseNA
Planned participants280
Who can joinFemale, 20 Years to 65 Years
Healthy volunteersNo

About this study

This study's primary goal is to compare the efficacy and safety of the novel advanced hemostatic device(AHD), Vi-Sealer, with conventional AHDs in laparoscopic total hysterectomy for patients with benign gynecologic neoplasm.

This description comes directly from the study's public registry record.

Talk to the study team

Hyun Park  ·  +82-031-780-5640  ·  p06162006@cha.ac.kr

Always discuss trial participation with your own doctor first.

Locations (1)

CHA Bundang Medical CenterSeongnam-si, Gyeonggi-do, South KoreaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05629611